Cargando…

UVB-induced bullous pemphigoid in a patient with psoriasis

Detalles Bibliográficos
Autores principales:	Ceryn, Justyna, Skibińska, Małgorzata, Barasiñska, Paulina, Noweta, Marcin, Narbutt, Joanna, Lesiak, Aleksandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953882/ https://www.ncbi.nlm.nih.gov/pubmed/35369632 http://dx.doi.org/10.5114/ada.2020.97725

Ejemplares similares

Pemphigoid Gestationis – Case Report and Review of Literature
por: Ceryn, Justyna, et al.
Publicado: (2021)

Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability
por: Narbutt, Joanna, et al.
Publicado: (2023)

A Priori Estimation of the Narrow-Band UVB Phototherapy Outcome for Moderate-to-Severe Psoriasis Based on the Patients’ Questionnaire and Blood Tests Using Random Forest Classifier
por: Narbutt, Joanna, et al.
Publicado: (2021)

Micronutrient deficiency with skin and systemic symptoms: a case report of acrodermatitis enteropathica
por: Rajczak, Maria, et al.
Publicado: (2023)

COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review
por: Ceryn, Justyna, et al.
Publicado: (2021)

AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
por: Olejniczak-Staruch, Irmina, et al.
Publicado: (2021)

Effectiveness and safety of secukinumab in patients with moderate-to-severe plaque psoriasis – a real life retrospective study
por: Galica, Katarzyna, et al.
Publicado: (2020)

Coexistence of psoriasis with bullous pemphigoid
por: Rao, Raghavendra, et al.
Publicado: (2012)

Demodicosis as an opportunistic infection in a patient with Crohn’s disease treated with infliximab
por: Niedźwiedź, Michał, et al.
Publicado: (2022)

Bullous pemphigoid and COVID-19 vaccine()
por: Pérez-López, Israel, et al.
Publicado: (2021)

Maculopapular rash in COVID-19 patient treated with lopinavir/ritonavir
por: Mazan, Paula, et al.
Publicado: (2020)

Trachyonychia successfully treated with low-dose acitretin in a paediatric patient
por: Siekierko, Aleksandra, et al.
Publicado: (2022)

Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine
por: Agharbi, F.-Z., et al.
Publicado: (2022)

Self‐resolving bullous pemphigoid induced by cemiplimab
por: Molle, Mattia Fabio, et al.
Publicado: (2022)

The Intriguing Links between Psoriasis and Bullous Pemphigoid
por: Maronese, Carlo Alberto, et al.
Publicado: (2022)

Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis
por: Olejniczak-Staruch, Irmina, et al.
Publicado: (2021)

Neurodegenerative disorders, bullous pemphigoid and psoriasis: a comparative study in ethnic Poles indicates that Parkinson’s disease is more relevant to bullous pemphigoid
por: Bartkiewicz, Paweł, et al.
Publicado: (2017)

Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19
por: Martora, Fabrizio, et al.
Publicado: (2023)

The Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review
por: Ciążyńska, Magdalena, et al.
Publicado: (2021)

Psoriasis and Atherosclerosis—Skin, Joints, and Cardiovascular Story of Two Plaques in Relation to the Treatment with Biologics
por: Wierzbowska-Drabik, Karina, et al.
Publicado: (2021)

Tumor of the Nose – A Rare Manifestation of a Metastatic Lung Cancer
por: Bolewska, Aleksandra, et al.
Publicado: (2021)

Case of papuloerythroderma of Ofuji‐like eruption during the course of bullous pemphigoid
por: Hayakawa‐Asai, Reina, et al.
Publicado: (2017)

Effectiveness and safety of Dupilumab for the treatment at 104 weeks of recalcitrant bullous pemphigoid
por: Manzo Margiotta, Flavia, et al.
Publicado: (2023)

Anti-desmoglein Autoantibody in a Patient with Bullous Pemphigoid - A Case Report
por: Rai, Reena, et al.
Publicado: (2022)

New‐onset bullous pemphigoid and flare of pre‐existing bullous pemphigoid after the third dose of the COVID‐19 vaccine
por: Bardazzi, Federico, et al.
Publicado: (2022)

Bullous Lichen Planus vs Lichen Planus Pemphigoides: A Diagnostic Dilemma
por: Tripathy, Durga M., et al.
Publicado: (2022)

Fatal hyalohyphomycosis with cutaneous involvement caused by Purpureocillium lilacinum in an immunocompromised patient with bullous pemphigoid
por: Corbeddu, Marialuisa, et al.
Publicado: (2021)

Bullous pemphigoid
por: Miyamoto, Denise, et al.
Publicado: (2019)

Bullous Pemphigoid Associated with Psoriasis, Breast Cancer and Parkinson’s Disease
por: STOICA, LOREDANA ELENA, et al.
Publicado: (2014)

Bullous pemphigoid associated with psoriasis: a good response to methotrexate
por: Vargas, Pablo, et al.
Publicado: (2019)

Bullous Pemphigoid Associated with Erythrodermic Psoriasis: A Case Report
por: Chen, Wenjuan, et al.
Publicado: (2022)

Pembrolizumab-induced bullous pemphigoid
por: Sun, Christina W., et al.
Publicado: (2019)

Seizures as a rare adverse effect of chloroquine therapy in systemic lupus erythematosus patients: a case report and literature survey
por: Krzeminski, Piotr, et al.
Publicado: (2018)

Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report
por: Pop, Samantha R., et al.
Publicado: (2022)

The role of inflammasomes in cutaneous pathology
por: Ciążyńska, Magdalena, et al.
Publicado: (2022)

Pros and cons of using systemic acitretin in the paediatric population
por: Sadowska, Magdalena, et al.
Publicado: (2020)

Off-label medications in the treatment of hospitalized children with atopic dermatitis
por: Niedźwiedź, Michał, et al.
Publicado: (2022)

Bullous Pemphigoid and Other Pemphigoid Dermatoses
por: Pratasava, Valeryia, et al.
Publicado: (2021)

Yellowish nodular changes in infants – juvenile xanthogranuloma and xanthoma
por: Hołdrowicz, Agnieszka, et al.
Publicado: (2021)

Erythrodermic psoriasis with bullous pemphigoid: combination treatment with methotrexate and compound glycyrrhizin
por: Si, Xiaoqing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cflu96lkaeif7rk0lgvqe4pubg